Sign In
Buy TOMDF
$0.000001
+0 (+0%)
At Close: Jun 02, 2026
Dr. Jorge Leone, Chief Scientific Officer of Todos Medical, and Sean Taylor, North American FAS Manager of Genscript, will discuss the importance of the cPass™ SARS-COV-2 neutralizing antibody test
Todos Medical in the business of saving lives with early disease detection
05:02am, Thursday, 14'th Oct 2021
Develops proprietary technology for blood-based disease testing Offers a comprehensive suite of coronavirus (COVID-19) testing solutions Developing significant programs in cancer and Alzheimer's diagn
Todos Medical gears up to expand its coronavirus testing services and clinical study
07:01am, Friday, 08'th Oct 2021
Todos Medical Ltd is firing on all cylinders. In September 2021, Tollovid and Tollovid Daily, the company's oral antiviral 3CL protease (MPro) inhibiting dietary supplements to support healthy immune
Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay TolloTest in a clinical study of coronavirus (COVID-19) patients.
Todos Medical Announces Positive Data in Hospitalized and Outpatient Setting for TolloTest™, a Novel SARS-CoV-2 3CL Protease Biomarker Assay
11:00am, Wednesday, 06'th Oct 2021
Data demonstrated very high correlation with PCR ct values in positive patients
UPDATE - Todos Medical Announces October Conference Calendar
06:00am, Tuesday, 05'th Oct 2021
NEW YORK, NY and Tel Aviv, ISRAEL, Oct. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solu
Todos Medical updates on its COVID-19 antiviral 3CL protease inhibitor Tollovir clinical development program in Israel
08:45am, Monday, 04'th Oct 2021
Todos Medical Ltd has provided an update on its coronavirus (COVID-19) oral antiviral 3CL protease inhibitor Tollovir clinical development program, which is currently enrolling in a Phase 2 clinical t
New York, NY, and Tel Aviv, ISRAEL, Oct. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related
Todos Medical Announces Positive Observational Trial Results for Oral Antiviral 3CL Protease (MPro) Inhibitor Tollovir®
09:08am, Thursday, 30'th Sep 2021
- Treatment group participants experienced a reduction in key inflammatory biomarker
Todos Medical Announces October Conference Calendar
09:09am, Tuesday, 28'th Sep 2021
New York, NY, and Tel Aviv, ISRAEL, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related
Todos Medical receives Amazon's approval to sell immune supplements Tollovid and Tollovid Daily
08:48am, Monday, 27'th Sep 2021
Todos Medical Ltd. has received approval from Amazon's e-commerce platform to sell Tollovid and Tollovid Daily, the company's 3CL protease (MPro) inhibiting dietary supplements to support healthy immu
Todos Medical Receives Approval by Amazon to Sell Immune Supplements Tollovid® & Tollovid Daily™
07:30am, Monday, 27'th Sep 2021
Tollovid® and Tollovid Daily™ are now available for immediate purchase on Amazon.com
Todos Medical sees 2Q revenue rocket to $1.7M, driven by sales from its coronavirus distribution business
11:46am, Friday, 24'th Sep 2021
Todos Medical Ltd, a medical diagnostics company, posted second-quarter results that saw its revenue rocket more than 50 times year-over-year fueled by its coronavirus (COVID-19) distribution business
Todos Medical Reports Second Quarter 2021 Financial Results
09:36am, Friday, 24'th Sep 2021
Company recorded positive earnings of $0.01 per share as financial condition improved
New York, NY, and Tel Aviv, ISRAEL, Sept. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, to
